78 related articles for article (PubMed ID: 10544522)
1. Beta-lactam antibiotics functionalized with gem-bisphosphonates.
Hornyák M; Hartmann JF; Sztaricskai FJ; Koncz A; Hernádi F
Acta Pharm Hung; 1999 Sep; 69(4):213-7. PubMed ID: 10544522
[TBL] [Abstract][Full Text] [Related]
2. Evaluation in an animal model and in vitro of the combination clavulanic acid and cephalosporins against beta-lactamase producing and nonproducing Staphylococcus aureus strains.
de Sá Del Fiol F; Rocha De Mattos Filho T; Groppo FC
Braz J Infect Dis; 2000 Feb; 4(1):36-42. PubMed ID: 10788844
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of the activity of cefaclor with amoxicillin, erythromycin and doxycycline in an in vitro model].
Wiedemann B
Arzneimittelforschung; 1983; 33(9):1232-5. PubMed ID: 6357205
[TBL] [Abstract][Full Text] [Related]
4. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
Ruczkowska J; Dolna I
Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
[No Abstract] [Full Text] [Related]
5. Preparation and activity of some novel organo-metallic complexes against Helicobacter pylori.
Nagarajan R; Mehta SI; Naik SR; Fabry W
Arzneimittelforschung; 1999 Nov; 49(11):951-4. PubMed ID: 10604049
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives.
Nam G; Kang TW; Shin JH; Choi KI
Bioorg Med Chem Lett; 2006 Feb; 16(3):569-72. PubMed ID: 16275089
[TBL] [Abstract][Full Text] [Related]
7. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2-oxoquinoline-3-carboxamide of ampicillin and amoxicillin as inhibitors of penicillin binding protein 1A of pseudomonas aeruginosa.
Shelke J; Meshram G; Dongre P
Acta Pol Pharm; 2012; 69(4):623-8. PubMed ID: 22876604
[TBL] [Abstract][Full Text] [Related]
9. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.
Falsafi T; Ehsani A; Niknam V
Indian J Med Microbiol; 2009; 27(4):335-40. PubMed ID: 19736403
[TBL] [Abstract][Full Text] [Related]
10. Introduction of a pyrrole cycle in cephalosporine structures as approach in the search for new beta-lactame antibiotics.
Bijev A; Radev I; Borisova Y
Pharmazie; 1999 Aug; 54(8):567-70. PubMed ID: 10483610
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity and resistance of Helicobacter pylori to antibiotic treatment].
Avidan B; Weiss B; Chowers Y; Younash A; Bar-Meir S; Keler N
Harefuah; 1999 Oct; 137(7-8):272-4, 352, 351. PubMed ID: 12415967
[TBL] [Abstract][Full Text] [Related]
12. [Resistance to antibiotics used in Helicobacter pylori infection in children].
Maciorkowska E; Kaczmarski M; Kowalczuk J; Kondej-Muszyńska K; Roszko I; Cieśla J; Zielińska A; Musaibili S
Pol Merkur Lekarski; 2004 Jun; 16(96):543-6. PubMed ID: 15510893
[TBL] [Abstract][Full Text] [Related]
13. Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Hu CT; Wu CC; Lin CY; Cheng CC; Su SC; Tseng YH; Lin NT
J Gastroenterol Hepatol; 2007 May; 22(5):720-3. PubMed ID: 17444862
[TBL] [Abstract][Full Text] [Related]
14. [Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Díaz-Reganon J; Alarcón T; Domingo D; López-Brea M
Rev Esp Quimioter; 2006 Mar; 19(1):34-8. PubMed ID: 16688289
[TBL] [Abstract][Full Text] [Related]
15. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
16. A novel colorimetric broth microdilution method to determine the minimum inhibitory concentration (MIC) of antibiotics and essential oils against Helicobacter pylori.
Weseler A; Geiss HK; Saller R; Reichling J
Pharmazie; 2005 Jul; 60(7):498-502. PubMed ID: 16076074
[TBL] [Abstract][Full Text] [Related]
17. Importance of inoculum growth phase when using an in vitro pharmacokinetic model to evaluate beta-lactam antibiotics.
Xerri L; Broggio R; Caro B; Scheda P
Chemioterapia; 1988 Apr; 7(2):79-85. PubMed ID: 3293819
[TBL] [Abstract][Full Text] [Related]
18. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
Paniagua GL; Monroy E; García O; Vaca S
Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
[TBL] [Abstract][Full Text] [Related]
19. Penicillin acylase-catalyzed synthesis of beta-lactam antibiotics in highly condensed aqueous systems: beneficial impact of kinetic substrate supersaturation.
Youshko MI; Moody HM; Bukhanov AL; Boosten WH; Svedas VK
Biotechnol Bioeng; 2004 Feb; 85(3):323-9. PubMed ID: 14748088
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro selective anti-Helicobacter pylori activity of N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides.
Chimenti F; Bizzarri B; Bolasco A; Secci D; Chimenti P; Carradori S; Granese A; Rivanera D; Lilli D; Scaltrito MM; Brenciaglia MI
Eur J Med Chem; 2006 Feb; 41(2):208-12. PubMed ID: 16377035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
